NCT07641790

Brief Summary

Hemiplegia, or paralysis of one side of the body, often results from stroke and severely limits arm function. Standard physiotherapy helps, but recovery is often slow. This study tests if adding a wearable vibratory device to standard therapy improves arm movement better than standard therapy alone. Thirty patients with subacute stroke (3-6 months) will be split into two groups. One group will receive usual physiotherapy, while the other will receive usual physiotherapy plus the vibratory device for 8 weeks. Doctors will measure changes in spasticity (muscle stiffness), motor function, and daily independence before and after treatment.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
1mo left

Started Feb 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress82%
Feb 2026Jul 2026

Study Start

First participant enrolled

February 1, 2026

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

June 6, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 11, 2026

Completed
19 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 15, 2026

Last Updated

June 11, 2026

Status Verified

June 1, 2026

Enrollment Period

5 months

First QC Date

June 6, 2026

Last Update Submit

June 6, 2026

Conditions

Keywords

VibrationUpper ExtremityPhysical TherapySubacute Stroke

Outcome Measures

Primary Outcomes (2)

  • Change in Upper Limb Spasticity

    Measured by the Modified Ashworth Scale (MAS). Scale ranges from 0 (no increase in tone) to 4 (rigidity). A lower score indicates better outcome.

    Baseline (Week 0) and Post-intervention (Week 8)

  • Change in Upper Limb Motor Function

    Measured by the Fugl-Meyer Assessment for Upper Extremity (FMA-UE). Total score ranges from 0 to 66. A higher score indicates better motor recovery.

    Baseline (Week 0) and Post-intervention (Week 8)

Secondary Outcomes (1)

  • Change in Functional Independence

    Baseline (Week 0) and Post-intervention (Week 8)

Study Arms (2)

Wearable Vibration + Physiotherapy

EXPERIMENTAL

Participants receive conventional physiotherapy (45 min) plus a wearable vibratory device applied to the affected upper limb for 30 minutes during the session. Sessions occur 3 times/week for 8 weeks.

Device: Wearable Focal Muscle Vibrator

Conventional Physiotherapy Only

ACTIVE COMPARATOR

Participants receive conventional physiotherapy (45 min) without the vibratory device. Sessions occur 3 times/week for 8 weeks.

Device: Wearable Focal Muscle Vibrator

Interventions

A portable, battery-operated device worn on the forearm. It delivers high-frequency focal vibration (100-120 Hz) to the muscle belly (biceps/forearm extensors) to reduce spasticity and facilitate motor recruitment.

Conventional Physiotherapy OnlyWearable Vibration + Physiotherapy

Eligibility Criteria

Age30 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Unilateral hemiplegia secondary to stroke
  • Age between 30 and 60 years
  • Subacute stage (3 to 6 months post-stroke)
  • Fugl-Meyer Assessment (FMA) score between 20 and 50
  • Able to follow simple verbal commands

You may not qualify if:

  • Previous peripheral nerve injury or surgery affecting the upper limb
  • Fixed contractures or bony fractures in the affected limb
  • Complete sensory loss of the upper limb
  • Co-existing neurological conditions (e.g., Parkinson's, MS, Dementia)
  • Unstable cardiovascular conditions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Faisalabad

Faisalābad, Punjab Province, 3800, Pakistan

RECRUITING

MeSH Terms

Conditions

HemiplegiaStroke

Condition Hierarchy (Ancestors)

ParalysisNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesVascular DiseasesCardiovascular Diseases

Central Study Contacts

Dr. Anbreena Rasool, Doctor of Physical Therapy

CONTACT

Dr Muhammad Ateeb, PhD Public Health

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The physiotherapist administering the treatment and the patients cannot be blinded due to the nature of the device. However, the assessor conducting the Fugl-Meyer and Ashworth scale evaluations will be blinded to group allocation.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor, Department of Rehabilitation Sciences

Study Record Dates

First Submitted

June 6, 2026

First Posted

June 11, 2026

Study Start

February 1, 2026

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

July 15, 2026

Last Updated

June 11, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

Locations